COMBACTE-MAGNET’s WP6i Bristol-based team has been developing a toolkit to provide systematic and evidence-based guidance on how and when to involve the public in medicines development research, in particular antimicrobials: The Patient and Public Involvement (PPI) Toolkit.
- A Practical Guide to doing PPI in antimicrobial medicines development research; and
- The main Toolkit, which describes the content of the Practical Guide in more detail.
The documents can be downloaded below.
Ventilator-Associated Pneumonia Due to Stenotrophomonas maltophilia: Risk Factors and Outcome
BACKGROUND: Stenotrophomonas maltophilia (SM) is increasingly identified in intensive care unit (ICU). This study aim to identify risk factors for SM ...
Accounting for length of hospital stay in regression models in clinical epidemiology
Mechanical Ventilation Impairs IL-17 Cytokine Family 3 Expression in Ventilator-Associated Pneumonia
Abstract. Mechanical ventilation (MV) is the primary risk factor for the development of ventilator-associated pneumonia (VAP). Besides inducing a pro-...